Society guideline links: Nontuberculous mycobacteria

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Bronchiectasis" and "Society guideline links: Cystic fibrosis" and "Society guideline links: Skin and soft tissue infections".)

International

●International Society of Cardiovascular Infectious Diseases (ISCVID): Guidelines for the diagnosis, treatment, and prevention of disseminated Mycobacterium chimaera infection following cardiac surgery with cardiopulmonary bypass (2020)

Canada

●Canadian Public Health Laboratory Network (CPHLN): Device testing recommendations regarding non-tuberculous mycobacteria (NTM) contamination in heater-cooler units (2017)

●CPHLN: Interim laboratory testing guidance on detection of non-tuberculous mycobacteria (NTM) infections in post-operative patients exposed to heater cooler units (2016)

United States

●Centers for Disease Control and Prevention (CDC): Nontuberculous mycobacteria (NTM) infections – For health care providers

•Clinical overview

●US Department of Health and Human Services (HHS): Federally approved clinical practice guidelines for HIV/AIDS

•Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Disseminated Mycobacterium avium complex disease (2024)

•Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV – Mycobacterium avium complex disease (2019)

●American Academy of Pediatrics (AAP): Red Book – Nontuberculous mycobacteria (2024)

●American Thoracic Society (ATS)/European Respiratory Society (ERS)/European Society of Clinical Microbiology and Infectious Diseases (ESCMID)/Infectious Diseases Society of America (IDSA): An official clinical practice guideline for the treatment of nontuberculous mycobacterial pulmonary disease (2020)

●American Society of Transplantation (AST): Guidelines for the management of infections due to nontuberculous mycobacteria in solid organ transplant recipients (2019)

●US Cystic Fibrosis Foundation (CFF) and European Cystic Fibrosis Society (ECFS): Consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis (2016)

Europe

●American Thoracic Society (ATS)/European Respiratory Society (ERS)/European Society of Clinical Microbiology and Infectious Diseases (ESCMID)/Infectious Diseases Society of America (IDSA): An official clinical practice guideline for the treatment of nontuberculous mycobacterial pulmonary disease (2020)

●US Cystic Fibrosis Foundation (CFF) and European Cystic Fibrosis Society (ECFS): Consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis (2016)

United Kingdom

●British Thoracic Society (BTS): Guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) (2017)

●Public Health England (PHE): Guidance and advice for health professionals on Mycobacterium chimaera infections associated with cardiopulmonary bypass (2017)

●PHE: Guidance on Mycobacterium chimaera infections – Information for GPs (2017)